Reassessing Chronic Illness

On The Pump Handle, Liz Borkowski surveys a new report on chronic illness released by the Institute of Medicine. Borkowski writes, "diabetes and heart disease are what leap to my mind—in part because they're so tied to the lifestyle factors of smoking, inadequate exercise, and poor nutrition, and in part because they cost our health system so much money." But other physical (and mental) afflictions beleaguer tens of millions of Americans (116 million of which, for example, suffer from chronic pain). In total, the IoM report "highlights nine 'clinical clusters' that together 'encompass and flesh out the range of key issues that affect the quality of life of patients with the full spectrum of chronic illnesses,'" and Borkowski summarizes each of them. She also notes that "more than one-fourth of the US population has two or more chronic conditions and the prevalence of multiple chronic conditions increases with age." Managing and perhaps someday preventing chronic illness will make for a happier future, but each disease presents its own complex dynamics. On ERV, Abbie Smith explains that cancer can develop resistance to treatment just like bacteria and viruses do. She writes, "Because of the genomic diversity of the population of tumor/bacteria/virus, when you apply the treatment, there is a small sub-population that is resistant to the treatment."

More like this

I wrote last month about the role of chronic diseases in healthcare-cost growth, so I was excited to see a new report from the Institute of Medicine called Living Well with Chronic Illness: A Call for Public Health Action. When I think of chronic illness, diabetes and heart disease are what leap…
Last time I talked about why treating cancer is so hard:Why havent we cured cancer yeeeeeet? Briefly, scientists did complete genome sequencing of seven individuals prostate tumors, and things were all kinds of jacked up. Not only were all seven tumors different, but one tumor had over 200…
On The Pump Handle, Liz Borkowski examines the ethical dilemma of testing the anthrax vaccine in children. If a widespread attack were to occur, we would want to know the safety and efficacy of the vaccine beforehand. But is an attack likely enough to warrant testing the vaccine on children? On…
A groundbreaking study published in PLOS ONE offers hope that scientists can reverse the development of antibiotic resistance among bacteria with the help of "a mathematical model that pinpoints optimal antibiotic cycling patterns." On The Pump Handle, Kim Krisberg writes, "the research comes at a…